Molecular oncology

Keyphrases

Publications

volume 18, number 7, 2024

Josquin Moraly, Taisuke Kondo, Mehdi Benzaoui, Justyn DuSold, Sohan Talluri, Marie C Pouzolles, Christopher Chien, Valérie Dardalhon, Naomi Taylor
Metabolic dialogues: regulators of chimeric antigen receptor T cell function in the tumor microenvironment. Molecular oncology 18 (7) (2024)
Helga Simon-Molas, Rosita Del Prete, Anna Kabanova
Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathways. Molecular oncology 18 (7) (2024)

volume 18, number 8, 2024

Sir Harpal Kumar
Alternative endpoints to mortality in cancer screening trials. Molecular oncology 18 (8) (2024)
Minmin Wang, Linzi Jia, Xiangpeng Dai, Xiaoling Zhang
Advanced strategies in improving the immunotherapeutic effect of CAR-T cell therapy. Molecular oncology 18 (8) (2024)
Anita G Kansy, Ramy Ashry, Al-Hassan M Mustafa, Abdallah M Alfayomy, Markus P Radsak, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver Holger Krämer
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. Molecular oncology 18 (8) (2024)
Akshatha N Srinivas, Diwakar Suresh, Prashant M Vishwanath, Suchitha Satish, Prasanna K Santhekadur, Saisudha Koka, Divya P Kumar
TACE inhibition: a promising therapeutic intervention against AATF-mediated steatohepatitis to hepatocarcinogenesis. Molecular oncology 18 (8) (2024)
Shohei Yoshida, Daisuke Kajiwara, Masanao Seki, Manabu Tayama, Yuki Tanaka, Hiroya Mizutani, Ryoto Fujita, Keisuke Yamamura, Shigeo Okajima, Masanori Asai, Kazuhisa Minamiguchi
TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer. Molecular oncology 18 (8) (2024)
Minmin Wang, Linzi Jia, Xiangpeng Dai, Xiaoling Zhang
Advanced strategies in improving the immunotherapeutic effect of CAR-T cell therapy. Molecular oncology 18 (8) (2024)
Akshatha N Srinivas, Diwakar Suresh, Prashant M Vishwanath, Suchitha Satish, Prasanna K Santhekadur, Saisudha Koka, Divya P Kumar
TACE inhibition: a promising therapeutic intervention against AATF-mediated steatohepatitis to hepatocarcinogenesis. Molecular oncology 18 (8) (2024)
Craig A Vincent, Silvia Remeseiro
The immune response behind peptide vaccination in diffuse midline glioma. Molecular oncology 18 (8) (2024)
Andrea Vallés-Martí, Richard R de Goeij-de Haas, Alex A Henneman, Sander R Piersma, Thang V Pham, Jaco C Knol, Joanne Verheij, Frederike Dijk, Hans Halfwerk, Elisa Giovannetti, Connie R Jiménez, Maarten F Bijlsma
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues. Molecular oncology 18 (8) (2024)
Dev Karan, Seema Dubey, Sumedha Gunewardena, Kenneth A Iczkowski, Manohar Singh, Pengyuan Liu, Angelo Poletti, Yeun-Mun Choo, Hui-Zi Chen, Mark T Hamann
Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice. Molecular oncology 18 (8) (2024)
Dev Karan, Seema Dubey, Sumedha Gunewardena, Kenneth A Iczkowski, Manohar Singh, Pengyuan Liu, Angelo Poletti, Yeun-Mun Choo, Hui-Zi Chen, Mark T Hamann
Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Shohei Yoshida, Daisuke Kajiwara, Masanao Seki, Manabu Tayama, Yuki Tanaka, Hiroya Mizutani, Ryoto Fujita, Keisuke Yamamura, Shigeo Okajima, Masanori Asai, Kazuhisa Minamiguchi
TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer. Molecular oncology 18 (8) (2024)
Olivier Romito, Aude Lemettre, Aurélie Chantôme, Ophélie Champion, Noémie Couty, Lobna Ouldamer, Nadine Hempel, Mohamed Trebak, Caroline Goupille, Marie Potier-Cartereau
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells. Molecular oncology 18 (8) (2024)
Anita G Kansy, Ramy Ashry, Al-Hassan M Mustafa, Abdallah M Alfayomy, Markus P Radsak, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver Holger Krämer
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. Molecular oncology 18 (8) (2024)
Dev Karan, Seema Dubey, Sumedha Gunewardena, Kenneth A Iczkowski, Manohar Singh, Pengyuan Liu, Angelo Poletti, Yeun-Mun Choo, Hui-Zi Chen, Mark T Hamann
Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice. Molecular oncology 18 (8) (2024)
Shohei Yoshida, Daisuke Kajiwara, Masanao Seki, Manabu Tayama, Yuki Tanaka, Hiroya Mizutani, Ryoto Fujita, Keisuke Yamamura, Shigeo Okajima, Masanori Asai, Kazuhisa Minamiguchi
TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer. Molecular oncology 18 (8) (2024)
Olivier Romito, Aude Lemettre, Aurélie Chantôme, Ophélie Champion, Noémie Couty, Lobna Ouldamer, Nadine Hempel, Mohamed Trebak, Caroline Goupille, Marie Potier-Cartereau
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells. Molecular oncology 18 (8) (2024)
Sir Harpal Kumar
Alternative endpoints to mortality in cancer screening trials. Molecular oncology 18 (8) (2024)
Thomas Fleischer, Mads Haugland Haugen, Jørgen Ankill, Laxmi Silwal-Pandit, Anne-Lise Børresen-Dale, Ingrid Hedenfalk, Thomas Hatschek, Jörg Tost, Olav Engebraaten, Vessela N Kristensen
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer. Molecular oncology 18 (8) (2024)
Sir Harpal Kumar
Alternative endpoints to mortality in cancer screening trials. Molecular oncology 18 (8) (2024)
Yonghwan Shin, Sungmin Kim, Gangning Liang, Woojin An
MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis. Molecular oncology 18 (8) (2024)
Olivier Romito, Aude Lemettre, Aurélie Chantôme, Ophélie Champion, Noémie Couty, Lobna Ouldamer, Nadine Hempel, Mohamed Trebak, Caroline Goupille, Marie Potier-Cartereau
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells. Molecular oncology 18 (8) (2024)
Jeon Yeob Jang, Bok-Soon Lee, Mei Huang, Chorong Seo, Ji-Hye Choi, Yoo Seob Shin, Hyun Goo Woo, Chul-Ho Kim
Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD-L1-expressing head and neck cancer. Molecular oncology 18 (8) (2024)
Anita G Kansy, Ramy Ashry, Al-Hassan M Mustafa, Abdallah M Alfayomy, Markus P Radsak, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver Holger Krämer
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. Molecular oncology 18 (8) (2024)
Andrea Vallés-Martí, Richard R de Goeij-de Haas, Alex A Henneman, Sander R Piersma, Thang V Pham, Jaco C Knol, Joanne Verheij, Frederike Dijk, Hans Halfwerk, Elisa Giovannetti, Connie R Jiménez, Maarten F Bijlsma
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues. Molecular oncology 18 (8) (2024)
Minmin Wang, Linzi Jia, Xiangpeng Dai, Xiaoling Zhang
Advanced strategies in improving the immunotherapeutic effect of CAR-T cell therapy. Molecular oncology 18 (8) (2024)
Thomas Fleischer, Mads Haugland Haugen, Jørgen Ankill, Laxmi Silwal-Pandit, Anne-Lise Børresen-Dale, Ingrid Hedenfalk, Thomas Hatschek, Jörg Tost, Olav Engebraaten, Vessela N Kristensen
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer. Molecular oncology 18 (8) (2024)
Yonghwan Shin, Sungmin Kim, Gangning Liang, Woojin An
MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis. Molecular oncology 18 (8) (2024)
Yi-Cheng Pan, Pei-Yi Chu, Ching-Chan Lin, Ching-Yun Hsieh, Wei-Yu Hsu, Lie-Fen Shyur, Juan-Cheng Yang, Wei-Chao Chang, Yang-Chang Wu
Glutathione S-transferase omega class 1 (GSTO1)-associated large extracellular vesicles are involved in tumor-associated macrophage-mediated cisplatin resistance in bladder cancer. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Jeon Yeob Jang, Bok-Soon Lee, Mei Huang, Chorong Seo, Ji-Hye Choi, Yoo Seob Shin, Hyun Goo Woo, Chul-Ho Kim
Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD-L1-expressing head and neck cancer. Molecular oncology 18 (8) (2024)
Tet Woo Lee, Dean C Singleton, Julia K Harms, Man Lu, Sarah P McManaway, Amy Lai, Moana Tercel, Frederik B Pruijn, Andrew M J Macann, Francis W Hunter, William R Wilson, Stephen M F Jamieson
Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models. Molecular oncology 18 (8) (2024)
Craig A Vincent, Silvia Remeseiro
The immune response behind peptide vaccination in diffuse midline glioma. Molecular oncology 18 (8) (2024)
Andrea Vallés-Martí, Richard R de Goeij-de Haas, Alex A Henneman, Sander R Piersma, Thang V Pham, Jaco C Knol, Joanne Verheij, Frederike Dijk, Hans Halfwerk, Elisa Giovannetti, Connie R Jiménez, Maarten F Bijlsma
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues. Molecular oncology 18 (8) (2024)
Thomas Fleischer, Mads Haugland Haugen, Jørgen Ankill, Laxmi Silwal-Pandit, Anne-Lise Børresen-Dale, Ingrid Hedenfalk, Thomas Hatschek, Jörg Tost, Olav Engebraaten, Vessela N Kristensen
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer. Molecular oncology 18 (8) (2024)
Yonghwan Shin, Sungmin Kim, Gangning Liang, Woojin An
MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis. Molecular oncology 18 (8) (2024)
Yi-Cheng Pan, Pei-Yi Chu, Ching-Chan Lin, Ching-Yun Hsieh, Wei-Yu Hsu, Lie-Fen Shyur, Juan-Cheng Yang, Wei-Chao Chang, Yang-Chang Wu
Glutathione S-transferase omega class 1 (GSTO1)-associated large extracellular vesicles are involved in tumor-associated macrophage-mediated cisplatin resistance in bladder cancer. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Jeon Yeob Jang, Bok-Soon Lee, Mei Huang, Chorong Seo, Ji-Hye Choi, Yoo Seob Shin, Hyun Goo Woo, Chul-Ho Kim
Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD-L1-expressing head and neck cancer. Molecular oncology 18 (8) (2024)
Tet Woo Lee, Dean C Singleton, Julia K Harms, Man Lu, Sarah P McManaway, Amy Lai, Moana Tercel, Frederik B Pruijn, Andrew M J Macann, Francis W Hunter, William R Wilson, Stephen M F Jamieson
Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models. Molecular oncology 18 (8) (2024)
Yonghwan Shin, Sungmin Kim, Gangning Liang, Woojin An
MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis. Molecular oncology 18 (8) (2024)
Yi-Cheng Pan, Pei-Yi Chu, Ching-Chan Lin, Ching-Yun Hsieh, Wei-Yu Hsu, Lie-Fen Shyur, Juan-Cheng Yang, Wei-Chao Chang, Yang-Chang Wu
Glutathione S-transferase omega class 1 (GSTO1)-associated large extracellular vesicles are involved in tumor-associated macrophage-mediated cisplatin resistance in bladder cancer. Molecular oncology 18 (8) (2024)
Craig A Vincent, Silvia Remeseiro
The immune response behind peptide vaccination in diffuse midline glioma. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Akshatha N Srinivas, Diwakar Suresh, Prashant M Vishwanath, Suchitha Satish, Prasanna K Santhekadur, Saisudha Koka, Divya P Kumar
TACE inhibition: a promising therapeutic intervention against AATF-mediated steatohepatitis to hepatocarcinogenesis. Molecular oncology 18 (8) (2024)
Olivier Romito, Aude Lemettre, Aurélie Chantôme, Ophélie Champion, Noémie Couty, Lobna Ouldamer, Nadine Hempel, Mohamed Trebak, Caroline Goupille, Marie Potier-Cartereau
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells. Molecular oncology 18 (8) (2024)
Tet Woo Lee, Dean C Singleton, Julia K Harms, Man Lu, Sarah P McManaway, Amy Lai, Moana Tercel, Frederik B Pruijn, Andrew M J Macann, Francis W Hunter, William R Wilson, Stephen M F Jamieson
Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models. Molecular oncology 18 (8) (2024)